Mi SciELO
Servicios Personalizados
Revista
Articulo
Indicadores
Citado por SciELO
Accesos
Links relacionados
Citado por Google
Similares en SciELO
Similares en Google
Compartir
Revista de la Sociedad Española de Enfermería Nefrológica
versión impresa ISSN 1139-1375
Resumen
DOMINGUEZ TRISTANCHO, Carmen; MACHADO GUZMAN, Visitación; MARQUEZ BENITEZ, Jesús y GOMEZ AINSUA, Cristina. Incidence of peritonitis caused by oxacillin-cephazolin resistant germs in peritoneal dialysis. Rev Soc Esp Enferm Nefrol [online]. 2005, vol.8, n.3, pp.51-54. ISSN 1139-1375.
Coagulase-negative Staphylococcus and Staphylococcus aureus continue to the germs most often responsible for peritonitis in patients treated using peritoneal dialysis. A variable portion of these germs have developed resistance to antibiotics such as oxacillin, cephazolin and glycopeptides. A total of 75 cases of peritonitis occurring in the last 5 years in 38 patients were analysed, to determine the percentage of gram positive germs resistant to oxacillin-cephazolin and to describe the evolution of these cases of peritonitis with empirical treatment with teicoplanine-cephtazidime, investigating the distinctive characteristics with respect to cases of peritonitis caused by germs that are sensitive to these antibiotics. The results of the cultures were: sterile 15%, coagulase negative Staphylococcus 37%, Staphylococcus aureus 8%, gram negatives 23%, other gram positives 13% and others 4%. No resistance to teicoplanine was found in any of the gram positive germs, nor to cephtazidime in the gram negatives; however, 50% of Staphylococcus were resistant to oxacillin and cephazolin. The percentage curation rate was over 90%, it not being possible to determine any distinguishing characteristics. In conclusion, the high curation rate in gram positive peritonitis treated with teicoplanine-cephtazidime is a further argument in favour of validating this treatment as the choice in peritoneal dialysis peritonitis.
Palabras clave : Peritoneal dialysis; Peritonitis; Teicoplanine-Cephtazidime.